Log in or Sign up for Free to view tailored content for your specialty!
Reactive Arthritis News

EULAR: Start inflammatory arthritis therapies ‘without delay’ after cancer remission
Targeted therapies for active inflammatory arthritis should be started “without delay” for patients with cancer in remission, according to new EULAR points to consider published in Annals of the Rheumatic Diseases.
Low IL-18 levels may predict long COVID risk in systemic autoimmune rheumatic diseases

WASHINGTON — Among patients with systemic autoimmune rheumatic diseases, circulating interleukin-18 levels were lower in those with long COVID vs. those without, according to data presented at ACR Convergence 2024.
'Better imaging' can improve understanding of inflammatory arthritis

SAN DIEGO — New imaging technologies, and improved use of the ones currently available, may move rheumatology closer to precision medicine in inflammatory arthritis, according to a speaker at the 2024 Congress of Clinical Rheumatology West.
Log in or Sign up for Free to view tailored content for your specialty!
Lab results, symptom tracking top list of key metrics among rheumatology patients

The ability to view laboratory results, track symptoms and sharing them with a provider were rated as the most useful potential app functions by patients with rheumatic and musculoskeletal diseases, according to data.
EULAR: Physical activity, regular assessment recommended for fatigue in inflammatory RMD

Fatigue in patients with inflammatory rheumatic and musculoskeletal diseases should be addressed with tailored physical activity, psychoeducational interventions or possibly immunomodulatory treatment, according to EULAR recommendations.
Poverty, chronic inflammation have ‘synergistic’ impact driving all-cause, cancer mortality

Poverty and chronic inflammation together may have a “synergistic” impact leading to higher all-cause mortality, including a 127% increased heart disease mortality risk and a 196% higher risk for cancer mortality, according to data.
Biologic DMARDs control ICI-associated inflammatory arthritis quicker than methotrexate

Patients with immune checkpoint inhibitor-associated inflammatory arthritis who receive a biologic DMARD demonstrate quicker arthritis control, but also experience faster cancer progression, vs. methotrexate, according to data.
EULAR: Routine, proactive therapeutic drug monitoring unnecessary in RMDs

Routine, proactive therapeutic drug monitoring for patients receiving biopharmaceuticals for rheumatic and musculoskeletal diseases is not recommended, according to new points-to-consider published by EULAR.
United Rheumatology, CreakyJoints launch RA resource during Arthritis Awareness Month

United Rheumatology and CreakyJoints have announced a partnership to launch the Rheumatoid Arthritis Wellness Center, a digital resource that aims to offer support to patients living with RA, according to a press release.
New drugs, new guidelines: ACR/AAHKS update treatment recommendations in joint replacement

Joint replacement in patients with inflammatory arthritis is often beset with pitfalls like disease flares and infectious complications, and up until recently, the emergence new treatments were rendering the current guidelines outdated.
-
Headline News
Veterinarians had undetected bird flu infections, but such cases are rare, CDC says
February 19, 20252 min read -
Headline News
Semaglutide may raise risk for form of optic neuropathy in adults with type 2 diabetes
February 20, 20253 min read -
Headline News
CDC disease detectives ‘remain in their positions,’ agency says
February 20, 20253 min read
-
Headline News
Veterinarians had undetected bird flu infections, but such cases are rare, CDC says
February 19, 20252 min read -
Headline News
Semaglutide may raise risk for form of optic neuropathy in adults with type 2 diabetes
February 20, 20253 min read -
Headline News
CDC disease detectives ‘remain in their positions,’ agency says
February 20, 20253 min read